Research reveals a new cyclohexanone monooxygenase that efficiently produces chiral lactones, suggesting its utility in complex natural product synthesis.
The stereoselective Baeyer–Villiger (BV) oxidation of 4,4-disubstituted cyclohexanones to chiral ε-lactones bearing quaternary stereocenters remains an unsolved challenge. Existing chiral metal complex catalysts, organocatalysts, and Baeyer–Villiger monooxygenases (BVMOs) are largely ineffective against these sterically hindered substrates despite working well with 4-monosubstituted analogues. Herein, we report the discovery and engineering of a cyclohexanone monooxygenase from Ruegeria sp. R14 (RuCHMO). It catalyzes the asymmetric BV oxidation of both 4,4-disubstituted and 4-monosubstituted cyclohexanones, providing efficient access to chiral S-configured ε-lactones bearing either quaternary or tertiary stereocenters. Through semirational engineering, the optimized variant Mu2 (RuCHMO-F490M/L201I) exhibits enhanced catalytic efficiency (up to 97% isolated yield and >99% ee) and broad substrate scope. The synthetic utility of this methodology is demonstrated by a concise chemoenzymatic total synthesis of the complex alkaloid (+)-kopsiyunnanine K, highlighting its potential in the synthesis of complex natural products.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: